84 related articles for article (PubMed ID: 2872235)
1. Medication effects on one-carbon metabolism in schizophrenia, mania, and major depression.
Morere DA; Alarcon RD; Monti JA; Walter-Ryan WG; Bancroft AJ; Smythies JR; Tolbert LC
J Clin Psychopharmacol; 1986 Jun; 6(3):155-61. PubMed ID: 2872235
[TBL] [Abstract][Full Text] [Related]
2. One-carbon metabolism disturbances in affective disorders. A preliminary report.
Alarcon RD; Tolbert LC; Monti JA; Morere DA; Walter-Ryan WG; Kemp B; Smythies JR
J Affect Disord; 1985 Nov; 9(3):297-301. PubMed ID: 2934462
[TBL] [Abstract][Full Text] [Related]
3. Clinical correlations of one-carbon metabolism abnormalities.
Tolbert LC; Monti JA; Walter-Ryan W; Alarcon RD; Bahar B; Keriotis JT; Allison JG; Cates A; Antun F; Smythies JR
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(4):491-502. PubMed ID: 3406427
[TBL] [Abstract][Full Text] [Related]
4. Abnormalities of one-carbon metabolism in psychiatric disorders: study of methionine adenosyltransferase kinetics and lipid composition of erythrocyte membranes.
Smythies JR; Alarcon RD; Morere D; Monti JA; Steele M; Tolbert LC; Walter-Ryan WG
Biol Psychiatry; 1986 Dec; 21(14):1391-8. PubMed ID: 3790625
[TBL] [Abstract][Full Text] [Related]
5. Kinetic evidence for decreased methionine adenosyltransferase activity in erythrocytes from schizophrenics.
Kelsoe JR; Tolbert LC; Crews EL; Smythies JR
J Neurosci Res; 1982; 8(1):99-103. PubMed ID: 7175980
[TBL] [Abstract][Full Text] [Related]
6. MAT kinetics in affective disorders and schizophrenia. An account.
Tolbert LC
Ala J Med Sci; 1988 Jul; 25(3):291-6. PubMed ID: 3177804
[No Abstract] [Full Text] [Related]
7. High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides.
Schwarz E; Prabakaran S; Whitfield P; Major H; Leweke FM; Koethe D; McKenna P; Bahn S
J Proteome Res; 2008 Oct; 7(10):4266-77. PubMed ID: 18778095
[TBL] [Abstract][Full Text] [Related]
8. Rational polypharmacy in the bipolar affective disorders.
Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
[TBL] [Abstract][Full Text] [Related]
9. [Antidepressive effect of pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor depression--preliminary open-label trial].
Shiloh R; Weizman A; Weizer N; Dorfman-Etrog P; Munitz H
Harefuah; 2001 May; 140(5):369-73, 456. PubMed ID: 11419053
[TBL] [Abstract][Full Text] [Related]
10. The role of neuroleptics in manic-depressive illness.
Kane JM
J Clin Psychiatry; 1988 Nov; 49 Suppl():12-4. PubMed ID: 2903142
[TBL] [Abstract][Full Text] [Related]
11. [Complications of combined use of lithium salts and neuroleptics in patients with endogenous psychoses].
Mosolov SN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(3):115-21. PubMed ID: 6134409
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte and brain methionine adenosyltransferase activities in patients with schizophrenia.
Gomes-Trolin C; Yassin M; Gottfries CG; Regland B; Grenfeldt B; Hallman J; Prince J; Oreland L
J Neural Transm (Vienna); 1998; 105(10-12):1293-305. PubMed ID: 9928898
[TBL] [Abstract][Full Text] [Related]
13. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
[TBL] [Abstract][Full Text] [Related]
14. [Bipolar disorders--how to recognize and treat them].
Grunze H; Sasse J; Forsthoff A; Bauer M
MMW Fortschr Med; 2004 May; 146 Spec No 2():4-6, 8. PubMed ID: 15376694
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic results in acute phases of manic depressive and schizophrenic psychoses as possible predictors of the prophylactic effect.
Svestka J; Náhunek K
Act Nerv Super (Praha); 1989 Apr; 31(1):51-2. PubMed ID: 2571228
[No Abstract] [Full Text] [Related]
16. Toward convergence in the medication treatment of bipolar disorder and schizophrenia.
Citrome L; Goldberg JF; Stahl SM
Harv Rev Psychiatry; 2005; 13(1):28-42. PubMed ID: 15804932
[TBL] [Abstract][Full Text] [Related]
17. Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs.
Maes M; Goossens F; Scharpé S; Calabrese J; Desnyder R; Meltzer HY
Psychiatry Res; 1995 Oct; 58(3):217-25. PubMed ID: 8570777
[TBL] [Abstract][Full Text] [Related]
18. [Treatment and prevention of mania: lithium and alternatives].
Vestergaard P
Ugeskr Laeger; 1993 Aug; 155(32):2438-42. PubMed ID: 8102824
[TBL] [Abstract][Full Text] [Related]
19. Bipolar depression: a new role for atypical antipsychotics?
Keck PE
Bipolar Disord; 2005; 7 Suppl 4():34-40. PubMed ID: 15948765
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotics in bipolar disorder.
Gelenberg AJ; Hopkins HS
J Clin Psychiatry; 1996; 57 Suppl 9():49-52. PubMed ID: 8823350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
